Exactly. That's what I'm trying to get at.
I think the concern around mefloquine is the recognition of what has happened in the past and the illnesses that have come from it, which very well might be a different dynamic. Now we know the use of it has gone down significantly over the last 10 years to 5%. I'm sensing from what you're saying they have the option as to which anti-malarial drug they choose.